Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TSIS: WHAT IS GOING ON? -- Ignore unavailable to you. Want to Upgrade?

To: gregor who wrote (5145)	2/8/1999 9:14:00 PM
From: Skip_S	Respond to of 6931

Hello TSIS people....Read the last paragragh of this press release. They are one of our clients. However TSIS is not allowed to release this news yet. Company Press Release SOURCE: Safeskin Corporation Safeskin Awarded Long-Term Sole-Source Exam Glove Contract From Continuum Health Partners SAN DIEGO, Feb. 8 /PRNewswire/ -- Safeskin Corporation (Nasdaq: SFSK - news), a leading manufacturer of disposable latex and synthetic gloves for the healthcare, high-technology and scientific industries, today said that it has been awarded a five-year, sole-source examination glove contract from Continuum Health Partners. The contract, which begins immediately, includes Safeskin's powder-free latex and synthetic (non-latex) exam gloves. Safeskin expects to realize approximately $20 million in incremental revenue over the life of the contract. Continuum Health Partners, with over 3,000 beds and more than 3,700 physicians and dentists, is the largest provider of inpatient health services to New York State. Continuum's network includes distinguished medical institutions such as Beth Israel, St. Luke's-Roosevelt and Long Island College Hospital. ''We are pleased to announce our partnership with Continuum Health Partners, our second major sole-source award contract of the new year,'' said Richard Jaffe, Chairman, President, and Chief Executive Officer of Safeskin. ''Last month, Safeskin announced that it had been awarded a three-year national sole-source contract with Kaiser Permanente for powder-free latex and synthetic exam gloves. We believe that today's glove supply contracts are awarded on the basis of value, product quality and customer service -- three areas where Safeskin has differentiated itself from the competition. We will continue to leverage our leadership position in powder-free exam gloves to create significant market positions in synthetic, surgical and high-technology and scientific markets worldwide.'' Safeskin Corporation is a leading manufacturer of high quality disposable latex and synthetic medical examination gloves for the United States market and believes that it is the world's leading manufacturer of high quality disposable powder-free examination gloves. The Company produces gloves at its manufacturing facilities in Southeast Asia using proprietary formulations and processes. This press release contains forward-looking statements that involve risks and uncertainties, including the Company's ability to leverage its market leadership position in powder-free exam gloves to create significant or leading market positions in synthetic, surgical and high-technology and scientific markets worldwide. Actual results may differ materially from those anticipated in the above forward looking statements for various reasons including those and others that are identified in the Company's readily available and most recent Form 1O-Q and other filings with the Securities and Exchange Commission. In an increasing effort to keep our shareholders informed on current events, Safeskin is now utilizing an interactive voice response (IVR) system to automate shareholder access to news releases, earnings reports, financial statements and management updates. You may access this information by dialing 1-877-411-SFSK (7375). SOURCE: Safeskin Corporation